Literature DB >> 8645854

Development of human T-cell lymphotropic virus type I-associated adult T-cell leukemia/lymphoma during immunosuppressive treatment following renal transplantation.

P J Jenks1, W Y Barrett, M J Raftery, S M Kelsey, J D van der Walt, S P Kon, J Breuer.   

Abstract

Although it is recognized that there is an increased incidence of lymphoproliferative disorders among patients who have received immunosuppressive therapy following transportation, there have been few reports of adult T-cell leukemia/lymphoma (ATLL) developing in previously asymptomatic carriers of human T-cell lymphotropic virus type I (HTLV-I) who have undergone transplantation. We describe the development of such a tumor in a man who was HTLV-I-positive and received immunosuppressive treatment following renal transplantation. As the number of individuals in ethnic groups at risk for organ transplantation increases, it would seem prudent to screen such individuals for carriage of HTLV-I before transplantation and to follow them prospectively to confirm if transplantation and immunosuppression predispose to the development of ATLL.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8645854     DOI: 10.1093/clinids/21.4.992

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  11 in total

Review 1.  Transmission of tropical and geographically restricted infections during solid-organ transplantation.

Authors:  P Martín-Dávila; J Fortún; R López-Vélez; F Norman; M Montes de Oca; P Zamarrón; M I González; A Moreno; T Pumarola; G Garrido; A Candela; S Moreno
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

2.  Guidelines for the assessment and acceptance of potential brain-dead organ donors.

Authors:  Glauco Adrieno Westphal; Valter Duro Garcia; Rafael Lisboa de Souza; Cristiano Augusto Franke; Kalinca Daberkow Vieira; Viviane Renata Zaclikevis Birckholz; Miriam Cristine Machado; Eliana Régia Barbosa de Almeida; Fernando Osni Machado; Luiz Antônio da Costa Sardinha; Raquel Wanzuita; Carlos Eduardo Soares Silvado; Gerson Costa; Vera Braatz; Milton Caldeira Filho; Rodrigo Furtado; Luana Alves Tannous; André Gustavo Neves de Albuquerque; Edson Abdala
Journal:  Rev Bras Ter Intensiva       Date:  2016-09

3.  HTLV-I screening in Britain. Donors and recipients of organ transplants should also be screened.

Authors:  P Jenks; M J Raftery; J Breuer
Journal:  BMJ       Date:  1996-03-16

4.  Adult T-cell leukemia in a liver transplant recipient that did not progress after onset of graft rejection.

Authors:  Shinsuke Suzuki; Kimiharu Uozumi; Masahiko Maeda; Yoshiko Yamasuji; Shin-ichi Hashimoto; Yasuji Komorizono; Satsuki Owatari; Masahito Tokunaga; Kouichi Haraguchi; Naomichi Arima
Journal:  Int J Hematol       Date:  2006-06       Impact factor: 2.490

5.  Two-step nature of human T-cell leukemia virus type 1 replication in experimentally infected squirrel monkeys (Saimiri sciureus).

Authors:  F Mortreux; M Kazanji; A S Gabet; B de Thoisy; E Wattel
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

6.  Cyclosporine-induced immune suppression alters establishment of HTLV-1 infection in a rabbit model.

Authors:  Rashade A H Haynes; Evan Ware; Christopher Premanandan; Bevin Zimmerman; Lianbo Yu; Andrew J Phipps; Michael D Lairmore
Journal:  Blood       Date:  2009-11-20       Impact factor: 22.113

7.  Ciclosporin A proof of concept study in patients with active, progressive HTLV-1 associated myelopathy/tropical spastic paraparesis.

Authors:  Fabiola Martin; Hannah Castro; Carolyn Gabriel; Adine Adonis; Alexandra Fedina; Linda Harrison; Liz Brodnicki; Maria A Demontis; Abdel G Babiker; Jonathan N Weber; Charles R M Bangham; Graham P Taylor
Journal:  PLoS Negl Trop Dis       Date:  2012-06-12

8.  Dynamic interaction between STLV-1 proviral load and T-cell response during chronic infection and after immunosuppression in non-human primates.

Authors:  Sandrine Souquière; Augustin Mouinga-Ondemé; Maria Makuwa; Olivier Hermine; Mirdad Kazanji
Journal:  PLoS One       Date:  2009-06-25       Impact factor: 3.240

9.  Adult T-Cell Leukemia/Lymphoma in a Caucasian Patient After Sexual Transmission of Human T-Cell Lymphotropic Virus Type 1.

Authors:  David Sibon; Olivier Cassar; Isabelle Duga; Chantal Brouzes; David Ghez; Christophe Pasquier; Claire Sibon; Alexandra Desrames; Franck Mortreux; Eric Wattel; Ali Bazarbachi; Antoine Gessain; Olivier Hermine
Journal:  Open Forum Infect Dis       Date:  2015-03-06       Impact factor: 3.835

10.  Genetic landscape of T- and NK-cell post-transplant lymphoproliferative disorders.

Authors:  Elizabeth Margolskee; Vaidehi Jobanputra; Preti Jain; Jinli Chen; Karthik Ganapathi; Odelia Nahum; Brynn Levy; Julie Morscio; Vundavalli Murty; Thomas Tousseyn; Bachir Alobeid; Mahesh Mansukhani; Govind Bhagat
Journal:  Oncotarget       Date:  2016-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.